Trademark: 90730427
Status Date
Thursday, March 7, 2024
Filing Date
Monday, May 24, 2021
Published for Opposition
Tuesday, August 9, 2022
9 Downloadable computer application software for managing, administering, and monitoring medication adherence; downloadable computer application software for monitoring patient behavior; downloadable computer software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; electronic downloadable publications in the nature of data files, findings in the nature of papers and reports, evaluations in the nature of papers and reports, and reports in the field of medicine and pharmacology
44 Providing medical analysis services relating to the treatment of persons, namely, monitoring medication intake for purposes of analyzing medical treatment adherence; medical services being patient medication care management and medication adherence services, namely, communicating with patients regarding their medications and adherence to medication regimens for medical treatment and clinical research purposes; medication adherence programs, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage for medical treatment and clinical research purposes; providing medical information and medical monitoring information from remote locations via the Internet and telecommunication networks via patient monitoring devices that feed information to a website that can be accessed in real-time by medical professionals; providing a website featuring medical information in the nature of an online medical profile and medical record analysis service designed to provide patients and medical professionals with custom tailored information regarding medication adherence; medical services, namely, providing interactive medical monitoring and alert service for reminding patients of medication dosages and medication adherence for medical treatment and clinical research purposes
42 Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SAAS) services, featuring software for administering medication adherence programs, monitoring patient behavior, and enabling remote patient engagement to enable health care providers,clinical trial personnel, and clinical trial sponsors; providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in database management for use in drug development and analysis; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology
Mar 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2024
Sou Extension 3 Granted
Mar 7, 2024
Sou Extension 3 Filed
Mar 7, 2024
Sou Teas Extension Received
Oct 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2023
Sou Extension 2 Granted
Oct 3, 2023
Sou Extension 2 Filed
Oct 3, 2023
Sou Teas Extension Received
Mar 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2023
Sou Extension 1 Granted
Mar 1, 2023
Sou Extension 1 Filed
Mar 1, 2023
Sou Teas Extension Received
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 9, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Published For Opposition
Jul 20, 2022
Notification Of Notice Of Publication E-Mailed
Jul 6, 2022
Approved For Pub - Principal Register
Jul 5, 2022
Teas/Email Correspondence Entered
Jul 5, 2022
Correspondence Received In Law Office
Jul 5, 2022
Teas Response To Office Action Received
Feb 9, 2022
Notification Of Non-Final Action E-Mailed
Feb 9, 2022
Non-Final Action E-Mailed
Feb 9, 2022
Non-Final Action Written
Feb 4, 2022
Assigned To Examiner
Dec 15, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 15, 2021
Teas Change Of Correspondence Received
Dec 15, 2021
Teas Change Of Owner Address Received
Aug 19, 2021
New Application Office Supplied Data Entered
May 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
